Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.

Shi J, Zhao CB, Vollmer TL, Tyry TM, Kuniyoshi SM

Division of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA. jiong.shi@chw.edu

BACKGROUND: The role of apolipoprotein E (APOE) polymorphism has been well recognized in other cognitive neurodegenerative disorders, such as Alzheimer disease. Its role in multiple sclerosis (MS) is less clear, though studies indicate that 40% to 60% of patients with MS have evidence of cognitive impairment. OBJECTIVE: To determine whether there is an association between APOE epsilon 4 and cognitive deficits in MS. METHODS: We performed a standardized battery of neuropsychological tests investigating the four cognitive domains commonly impaired in MS and assessed the association of the presence of APOE epsilon 4 with cognition in MS. RESULTS: A strong association was found between the presence of APOE epsilon 4 and cognitive deficits in patients with MS, particularly in the domains of learning and memory. This association was strongest in our youngest cohort (age 31 to 40) of patients with MS. CONCLUSIONS: APOE epsilon 4 is significantly associated with cognitive impairment in patients with multiple sclerosis (MS). However, the modest effects do not justify APOE genotyping of patients with MS in clinical practice.

Published 15 January 2008 in Neurology, 70(3): 185-90.
Full-text of this article is available online (may require subscription).

© 2004-2008 Multiple Sclerosis Research Today. All Rights Reserved.